PapersPMID:34227198
Effect of flaxseed consumption on central obesity, serum lipids, and adiponectin level in overweight or obese women: A randomised controlled clinical trial.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- RCT · 3 months
- Dose studied, every finding
- 30 g/day milled flaxseed for 12 weeks
- Population, every finding
- overweight or obese women; balanced diet plus 30 g/day milled flaxseed versus balanced diet plus 30 g/day milled rice
What moved
How to read these marks →“After 12 weeks of intervention, there was significantly higher reduction rate in waist circumference (WC) and waist-to-hip ratio (WHR) (both P < .05) in the flaxseed-consuming group compared with the control group.”
- Decreases waist circumference
very limited
- Decreases waist-to-hip ratio
very limited
- Increases serum adiponectin
very limited
“Moreover, adiponectin level was significantly increased from (12.11 ± 7.1) to (17.15 ± 6.1) in the flaxseed-consuming group compared with the control group from (12.48 ± 4.7) to (12.01 ± 5.8) (P = .002).”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- overweight or obese women
- Participants
- 60
- Comparator
- an active treatment / placebo
- Duration
- 84 days
- Endpoints measured
- 4